ECE 2022
Real-life data on osilodrostat
www.high5endocrinology.tv | Meeting coverage | ECE 2022
ECE 2022
Real-life data on osilodrostat
ECE 2022
New development on hyperaldosteronism
ECE 2022
MRI controls after pituitary surgery without gadolinium
ECE 2022
The debate about pituitary adenoma vs. PitNET
ECE 2022
News about high-dose cabergoline in prolactinoma…
ECE 2022
Diabetes insipidus - the patient's perspective
ECE 2022
Anti-aging with bisphosphonates?
ECE 2022
Update on calcium metabolism disorders - PARAT
ECE 2022
Muscles and aging
ECE 2022
Malignant pheocromocytomas
ECE 2022
Aggressive pituitary tumors / pituitary carcinomas
ECE 2022
Differences in brain morphs and function in individuals…
ECE 2022
MKRN3 and puberty regulation
ECE 2022
Kisspeptin in men with low sexual desires
ECE 2022
PCOS - genetic or epigenetic?
ECE 2022
Old dogmas and new players in puberty and reproduction
ECE 2022
Transition from childhood to adolescence
ECE 2022
Long-term treatment with GLP-1 agonists
ECE 2022
Obesity - are we up to date?
ECE 2022
Iron and the thyroid
ECE 2022
Endocrine disruptors - the maternal behavior and…
Für den erfolgreichen Abschluss der Fortbildungsmodule ist die korrekte (mind. 70%) Beantwortung der Lernerfolgskontrolle für das jeweilige Modul verpflichtend.
Jetzt gleich den Fragebogen ausfüllen!